Lately, the M4R has been suggested to be a potential drug target for the treatment of neurodegenerative and neuropsychiatric disorders like Alzheimer's disease or schizophrenia [5,6]. The gene discussed is CHRM4; the disease is early-onset autosomal dominant Alzheimer disease.